findmyKOL
Clinical trialNCT00102245TerminatedObservational

Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes

SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrollment334AnemiasHemoglobinopathiesHemolysisIron Deficiency and Overload
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will examine blood for factors that may cause or prevent diseases involving iron or red blood cells. Iron is an important nutrient for human health that is needed to produce red blood cells. Red blood cells carry oxygen to body tissues. A better understanding of iron and red blood cells may help lead to better treatment of several diseases including anemia. Patients of all ages with red cell abnormalities in the following categories may be eligible for this study: * Diseases with deficiency, overload or maldistribution of iron * Known red blood cell diseases, such as anemias and hemoglobinopathies * Red blood cell diseases of unknown cause, such as hemolysis of unknown cause * Red blood cell abnormalities with no overt clinical disease, such as hereditary persistence of fetal hemoglobin Participants undergo the following procedures: * Medical history * Physical examination * Standard medical tests related to the individual's iron or red blood cell condition Blood draw for the following purposes: * Testing for syphilis and for the hepatitis B and C, HIV, and HTLV-1viruses, and for a pregnancy test for women who can become pregnant * Research purposes. This blood is analyzed for genes, proteins, sugars, and fat molecules.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Jeffery L Miller, M.D.

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Jan 2005
Primary completion
—
Completion
4 Aug 2017
Last update posted
14 Feb 2018
Registered enrollment
334
Registry id
NCT00102245

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.